Circulating fibroblast growth factor‐23 plasma levels predict adverse cardiovascular outcomes in patients with diabetes mellitus with coronary artery disease - Concepedia

Concepedia

Publication | Closed Access

Circulating fibroblast growth factor‐23 plasma levels predict adverse cardiovascular outcomes in patients with diabetes mellitus with coronary artery disease

36

Citations

31

References

2016

Year

José Tuñón, Beatriz Fernández‐Fernández, Rocío Carda, Ana María Pello, Carmen Cristóbal, Nieves Tarín, Álvaro Aceña, María Luisa González‐Casaus, Ana Huelmos, Joaquín Alonso,

Diabetes/Metabolism Research and Reviews

Abstract

FGF-23 plasma levels predict adverse cardiovascular outcomes in coronary artery disease patients who have T2D but not in those without T2D. This finding should be confirmed in larger studies. Copyright © 2016 John Wiley & Sons, Ltd.

References

	Year	Citations

Page 1